Revenue
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | £21.21B | £18.91B | £16.49B | £13.52B | £11.22B | £11.49B |
| Gross profit | £6.17B | £4.22B | £3.62B | £2.76B | £2.14B | −£187.0M |
| Gross margin | 29.12% | 22.32% | 21.96% | 20.39% | 19.04% | −1.63% |
| Research & development | £495.0M | £203.0M | £739.0M | £891.0M | £778.0M | £1.20B |
| Operating expenses | £1.71B | £1.31B | £1.68B | £1.92B | £1.62B | £1.78B |
| Operating income | £4.47B | £2.91B | £1.94B | £837.0M | £513.0M | −£1.97B |
| Operating margin | 21.07% | 15.37% | 11.79% | 6.19% | 4.57% | −17.16% |
| EBITDA | £8.14B | £3.48B | £3.74B | −£207.0M | — | — |
| EBITDA margin | 38.38% | 18.42% | 22.71% | −1.53% | — | — |
| Net income | £5.84B | £2.48B | £2.40B | −£1.27B | £121.0M | −£3.17B |
| Net profit margin | 27.52% | 13.14% | 14.58% | −9.42% | 1.08% | −27.58% |
| Basic EPSper basic share | £0.69 | £0.30 | £0.29 | -£0.15 | £0.01 | -£0.53 |
| Diluted EPSper diluted share | £0.69 | £0.30 | £0.29 | -£0.15 | £0.01 | -£0.53 |